Company Presentation

Molecular Partners AG

Category:Clinical Stage Development Company
Time:15:45 – 16:00
Speaker:Dr. Patrick Amstutz

Company profile

Molecular Partners AG is a clinical-stage biotech company developing DARPin® therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin® therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Further information

Follow us